다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

PCVX

Vaxcyte (PCVX)

Vaxcyte Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PCVX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	05:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05:05	GlobeNewswire Inc.	Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PCVX	Vaxcyte Inc
2024/04/03	05:05	GlobeNewswire Inc.	Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/04	22:30	GlobeNewswire Inc.	Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants	NASDAQ:PCVX	Vaxcyte Inc
2024/03/02	06:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/02	06:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06:58	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06:01	GlobeNewswire Inc.	Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:PCVX	Vaxcyte Inc
2024/02/21	06:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/16	06:05	GlobeNewswire Inc.	Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024	NASDAQ:PCVX	Vaxcyte Inc
2024/02/06	07:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/06	07:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/03	08:39	GlobeNewswire Inc.	Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06:07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06:05	GlobeNewswire Inc.	Vaxcyte to Present at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	NASDAQ:PCVX	Vaxcyte Inc
2024/02/01	07:26	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PCVX	Vaxcyte Inc
2024/02/01	07:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/01/31	13:37	GlobeNewswire Inc.	Vaxcyte Announces Pricing of $750 Million Public Offering	NASDAQ:PCVX	Vaxcyte Inc
2024/01/31	06:13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PCVX	Vaxcyte Inc
2024/01/31	06:01	GlobeNewswire Inc.	Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:PCVX	Vaxcyte Inc
2024/01/29	22:30	GlobeNewswire Inc.	Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older	NASDAQ:PCVX	Vaxcyte Inc
2024/01/17	06:01	GlobeNewswire Inc.	Vaxcyte Appoints Whitney Jones as Chief People Officer	NASDAQ:PCVX	Vaxcyte Inc
2024/01/05	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/01/05	06:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc

검색 관련기사 보기:NASDAQ:PCVX

1 2 3 4 5 6 7 8 9 10 다음 >>

Pine Cliff Energy

Vontobel Financial Produ...

Edward Jones Money Market Fund

Rolinco NV (GM)

NLBNPIT22BS7 20351221 29...

MFF Capital Investments

Atlas Financial (PK)

Pro Dv Software

BOA Acquisition

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관